Literature DB >> 9988844

Episodic memory and learning in patients with chronic schizophrenia.

T M Rushe1, P W Woodruff, R M Murray, R G Morris.   

Abstract

This study explored the pattern of memory functioning in 58 patients with chronic schizophrenia and compared their performance with 53 normal controls. Multiple domains of memory were assessed, including verbal and non-verbal memory span, verbal and non-verbal paired associate learning, verbal and visual long-term memory, spatial and non-spatial conditional associative learning, recognition memory and memory for temporal order. Consistent with previous studies, substantial deficits in long-term memory were observed, with relative preservation of memory span. Memory for temporal order and recognition memory was intact, although significant deficits were observed on the conditional associative learning tasks. There was no evidence of lateralized memory impairment. In these respects, the pattern of memory impairment in schizophrenia is more similar in nature to that found in patients with memory dysfunction following mesiotemporal lobe lesions, rather than that associated with focal frontal lobe damage.

Entities:  

Mesh:

Year:  1999        PMID: 9988844     DOI: 10.1016/s0920-9964(98)00117-0

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

1.  Patients with schizophrenia demonstrate inconsistent preference judgments for affective and nonaffective stimuli.

Authors:  Gregory P Strauss; Benjamin M Robinson; James A Waltz; Michael J Frank; Zuzana Kasanova; Ellen S Herbener; James M Gold
Journal:  Schizophr Bull       Date:  2010-05-19       Impact factor: 9.306

2.  Altered probabilistic learning and response biases in schizophrenia: behavioral evidence and neurocomputational modeling.

Authors:  James A Waltz; Michael J Frank; Thomas V Wiecki; James M Gold
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

3.  Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat.

Authors:  Philip L R Gaskin; Stephen P H Alexander; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

4.  The influence of encoding strategy on episodic memory and cortical activity in schizophrenia.

Authors:  Aaron Bonner-Jackson; Kristen Haut; John G Csernansky; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2005-07-01       Impact factor: 13.382

Review 5.  Animal models of schizophrenia.

Authors:  C A Jones; D J G Watson; K C F Fone
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

7.  Automatic and controlled response inhibition: associative learning in the go/no-go and stop-signal paradigms.

Authors:  Frederick Verbruggen; Gordon D Logan
Journal:  J Exp Psychol Gen       Date:  2008-11

8.  Reduced context effects on retrieval in first-episode schizophrenia.

Authors:  Lucia M Talamini; Lieuwe de Haan; Dorien H Nieman; Don H Linszen; Martijn Meeter
Journal:  PLoS One       Date:  2010-04-27       Impact factor: 3.240

Review 9.  Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms.

Authors:  Michael A Cirillo; Larry J Seidman
Journal:  Neuropsychol Rev       Date:  2003-06       Impact factor: 7.444

10.  Dominance of objects over context in a mediotemporal lobe model of schizophrenia.

Authors:  Lucia M Talamini; Martijn Meeter
Journal:  PLoS One       Date:  2009-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.